FIELD: medicine.
SUBSTANCE: method involves per os introducing lipoic acid concurrently with beta-carotene at a dose of 0.05 and 10 mg 3 times a day during 1 month, respectively.
EFFECT: enhanced effectiveness of treatment; improved antioxidation activity in eye tissues; improved vision function.
3 dwg, 1 tbl
Title | Year | Author | Number |
---|---|---|---|
METHOD OF IMPROVEMENT OF VISUAL FUNCTIONS AT PRIMARY OPEN ANGLE GLAUCOMA WITH NORMALISED INTRAOCULAR TENSION | 2007 |
|
RU2351299C1 |
METHOD FOR PREDICTING GLAUCOMA DEVELOPMENT COURSE | 1998 |
|
RU2139538C1 |
EYE DROPS FOR TREATING GLAUCOMA | 2002 |
|
RU2223099C1 |
METHOD FOR PREDICTION OF DEVELOPING PRIMARY OPEN-ANGLE GLAUCOMA | 2012 |
|
RU2517233C1 |
METHOD FOR PREDICTING RATE OF PROGRESSION OF GLAUCOMA OPTIC NEUROPATHY | 2017 |
|
RU2665005C1 |
METHOD OF TREATMENT OF GLAUCOMA OPTIC NEUROPATHY | 2006 |
|
RU2335283C2 |
METHOD OF TREATING ELDERLY AND SENILE GLAUCOMA OPTIC NEUROPATHY | 2009 |
|
RU2411033C1 |
METHOD FOR THERAPEUTIC TREATMENT OF PRIMARY OPEN-ANGLE GLAUCOMA | 2003 |
|
RU2244528C1 |
METHOD FOR PREVENTING APOPTOSIS OF GANGLIOUS CELLS IN PATIENTS WITH PRIMARY GLAUCOMA AT NORMAL INTRAOCULAR PRESSURE | 2003 |
|
RU2242955C1 |
METHOD OF TREATING ISCHEMIC TYPE OF PRIMARY OPEN-ANGLE GLAUCOMA IN INDIVIDUALS WITH NEAT SIGHT | 2010 |
|
RU2438670C1 |
Authors
Dates
2005-08-27—Published
2003-10-16—Filed